Orphan Medicines: The High Cost of Hope

Prescriber - United Kingdom
doi 10.1002/psb.1640
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Wiley

Related search

Php109 - Cost of Unlicenced and Orphan Medicines in Turkey, Kazakhstan and Poland

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Low Availability of Orphan Medicines in Serbia

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Php162 - Licenced Orphan Medicines Expenditure in Turkey

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Access to High Cost Medicines in Australia: Ethical Perspectives

Australia and New Zealand Health Policy
2008English

Erratum To: Establishing Medical Plausibility in the Context of Orphan Medicines Designation in the European Union

Orphanet Journal of Rare Diseases
MedicineGeneticsPharmacology
2015English

Hope for Fish on the High Seas

Nature Food
2020English

Safe and Sound: Applying Quality Use of Medicines to High‐risk Medicines

Journal of Pharmacy Practice and Research
PharmacologyPharmacy
2018English

Prescribing Errors by Junior Doctors- A Comparison of Errors With High Risk Medicines and Non-High Risk Medicines

PLoS ONE
Multidisciplinary
2019English

Prescribed Medicines Skipped Due to Cost, 2016 (Or Nearest Year)

Health at a Glance 2017
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy